GB0526498D0 - Method - Google Patents
MethodInfo
- Publication number
- GB0526498D0 GB0526498D0 GB0526498A GB0526498A GB0526498D0 GB 0526498 D0 GB0526498 D0 GB 0526498D0 GB 0526498 A GB0526498 A GB 0526498A GB 0526498 A GB0526498 A GB 0526498A GB 0526498 D0 GB0526498 D0 GB 0526498D0
- Authority
- GB
- United Kingdom
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0526498A GB0526498D0 (en) | 2005-12-28 | 2005-12-28 | Method |
PCT/GB2006/004930 WO2007074341A1 (en) | 2005-12-28 | 2006-12-22 | Detection of oesophageal cancer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0526498A GB0526498D0 (en) | 2005-12-28 | 2005-12-28 | Method |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0526498D0 true GB0526498D0 (en) | 2006-02-08 |
Family
ID=35841284
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0526498A Ceased GB0526498D0 (en) | 2005-12-28 | 2005-12-28 | Method |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0526498D0 (en) |
WO (1) | WO2007074341A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201005048D0 (en) | 2010-03-24 | 2010-05-12 | Medical Res Council | Prognosis of oesophageal and gastro-oesophageal junctional cancer |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2405431A1 (en) * | 2000-03-31 | 2001-10-11 | Gene Logic, Inc. | Gene expression profiles in esophageal tissue |
WO2001094629A2 (en) * | 2000-06-05 | 2001-12-13 | Avalon Pharmaceuticals | Cancer gene determination and therapeutic screening using signature gene sets |
WO2003040325A2 (en) * | 2001-02-01 | 2003-05-15 | Curagen Corporation | Novel proteins and nucleic acids encoding same |
US20030044815A1 (en) * | 2001-02-15 | 2003-03-06 | Susana Salceda | Compositions and methods relating to breast specific genes and proteins |
US20030065157A1 (en) * | 2001-04-04 | 2003-04-03 | Lasek Amy W. | Genes expressed in lung cancer |
EP1463928A2 (en) * | 2001-04-18 | 2004-10-06 | Protein Design Labs | Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer |
WO2004076614A2 (en) * | 2003-02-27 | 2004-09-10 | Bernd Hinzmann | Human nucleic acid sequences obtained from prostatic carcinomas |
EP1721159B1 (en) * | 2004-02-20 | 2014-12-10 | Janssen Diagnostics, LLC | Breast cancer prognostics |
-
2005
- 2005-12-28 GB GB0526498A patent/GB0526498D0/en not_active Ceased
-
2006
- 2006-12-22 WO PCT/GB2006/004930 patent/WO2007074341A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2007074341A1 (en) | 2007-07-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1864785A4 (en) | Seterolithography method | |
GB0504774D0 (en) | Method | |
GB0503836D0 (en) | Method | |
GB0512214D0 (en) | Method | |
GB0519303D0 (en) | Chemo-immunotherapy method | |
GB0520375D0 (en) | Method | |
GB0509433D0 (en) | Method | |
GB0504096D0 (en) | Method | |
GB0504184D0 (en) | Method | |
GB0507123D0 (en) | Method | |
GB0520235D0 (en) | Method | |
GB0510536D0 (en) | Method | |
GB0508420D0 (en) | Method | |
GB0505756D0 (en) | Method | |
GB0502046D0 (en) | Method | |
GB0509305D0 (en) | Method | |
GB0515695D0 (en) | Method | |
GB0509437D0 (en) | Method | |
GB0520981D0 (en) | Method | |
GB0518667D0 (en) | Method | |
GB0504182D0 (en) | Method | |
GB0506670D0 (en) | Method | |
GB0502360D0 (en) | Method | |
GB0526498D0 (en) | Method | |
GB0502542D0 (en) | Method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |